The transcriptional coregulator PGC-1β controls mitochondrial function and anti-oxidant defence in skeletal muscles

Nature Communications

Volumn 6, Issue , 2015, Pages

  Ramamoorthy, Thanuja Gali ^a   Laverny, Gilles ^a   Schlagowski, Anna Isabel ^a   Zoll, Joffrey ^a   Messaddeq, Nadia ^a   Bornert, Jean Marc ^a   Panza, Salvatore ^a,b   Ferry, Arnaud ^c   Geny, Bernard ^a   Metzger, Daniel ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b UNIVERSITY OF CALABRIA   (Italy)

^c INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; CARDIOLIPIN; MITOCHONDRIAL PROTEIN; MITOFUSIN 2; MYOSIN HEAVY CHAIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; SUCCINATE DEHYDROGENASE; FREE RADICAL; HYDROGEN PEROXIDE; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PPARGC1A PROTEIN, MOUSE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR;

ANTIOXIDANT; MITOCHONDRIAL DNA; MUSCLE; PHYSIOLOGICAL RESPONSE; PROTEIN; SKELETON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BROWN ADIPOSE TISSUE; CONTROLLED STUDY; DOWN REGULATION; ENERGY METABOLISM; EXERCISE; EXON; FATTY ACID OXIDATION; GASTROCNEMIUS MUSCLE; GLUCOSE HOMEOSTASIS; GRIP STRENGTH; LOXP SITE; MOUSE; MUSCLE CONTRACTILITY; MUSCLE MITOCHONDRION; MUSCLE STRENGTH; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PROTEIN SYNTHESIS; QUADRICEPS FEMORIS MUSCLE; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TIBIALIS ANTERIOR MUSCLE; ANIMAL; ELECTRON SPIN RESONANCE; ELECTROPORATION; EXERCISE TEST; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; GLUCOSE TOLERANCE TEST; HAND STRENGTH; INSULIN RESISTANCE; LIPID PEROXIDATION; METABOLISM; MUSCLE CONTRACTION; MYOBLAST; PATHOLOGY; PHYSIOLOGY; SKELETAL MUSCLE CELL;

MUS;

ANIMALS; ELECTRON SPIN RESONANCE SPECTROSCOPY; ELECTROPORATION; EXERCISE TEST; FREE RADICALS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; GLUCOSE TOLERANCE TEST; HAND STRENGTH; HYDROGEN PEROXIDE; INSULIN RESISTANCE; LIPID PEROXIDATION; MICE; MITOCHONDRIA, MUSCLE; MUSCLE CONTRACTION; MUSCLE FIBERS, SKELETAL; MUSCLE STRENGTH; MUSCLE, SKELETAL; MYOBLASTS; OXIDATIVE STRESS; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA COACTIVATOR 1-ALPHA; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTORS;

EID: 84950247738     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10210     Document Type: Article

References (70)

1. Lin, J., Puigserver, P., Donovan, J., Tarr, P. & Spiegelman, B. M. Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta ), a novel PGC-1-related transcription coactivator associated with host cell factor. J. Biol. Chem. 277, 1645-1648 (2002).
2. Kamei, Y. et al. PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity. Proc. Natl Acad. Sci. USA 100, 12378-12383 (2003).
3. Puigserver, P. et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829-839 (1998).
4. Spiegelman, B. M. Transcriptional control of mitochondrial energy metabolism through the PGC1 coactivators. Novartis Found. Symp. 287, 60-63 (2007); Discussion 63-69.
5. Scarpulla, R. C. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim. Biophys. Acta 1813, 1269-1278 (2011).
6. Koo, S. H. et al. PGC-1 promotes insulin resistance in liver through PPAR-alpha-dependent induction of TRB-3. Nat. Med. 10, 530-534 (2004).
7. Puigserver, P. et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 423, 550-555 (2003).
8. Arany, Z. et al. Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab. 1, 259-271 (2005).
9. St-Pierre, J. et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 127, 397-408 (2006).
10. Valle, I., Alvarez-Barrientos, A., Arza, E., Lamas, S. & Monsalve, M. PGC-1alpha regulates the mitochondrial antioxidant defense system in vascular endothelial cells. Cardiovasc. Res. 66, 562-573 (2005).
11. Lu, Z. et al. PGC-1 alpha regulates expression of myocardial mitochondrial antioxidants and myocardial oxidative stress after chronic systolic overload. Antioxid. Redox Signal. 13, 1011-1022 (2010).
12. Sonoda, J., Mehl, I. R., Chong, L. W., Nofsinger, R. R. & Evans, R. M. PGC-1beta controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis. Proc. Natl Acad. Sci. USA 104, 5223-5228 (2007).
13. Lin, J. et al. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell 120, 261-273 (2005).
14. Riehle, C. et al. PGC-1beta deficiency accelerates the transition to heart failure in pressure overload hypertrophy. Circ. Res. 109, 783-793 (2011).
15. Lelliott, C. J. et al. Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol. 4, e369 (2006).
16. Lai, L. et al. Transcriptional coactivators PGC-1alpha and PGC-lbeta control overlapping programs required for perinatal maturation of the heart. Genes Dev. 22, 1948-1961 (2008).
17. Barja, G. Mitochondrial oxygen radical generation and leak: sites of production in states 4 and 3, organ specificity, and relation to aging and longevity. J. Bioenerg. Biomembr. 31, 347-366 (1999).
18. Turrens, J. F. Mitochondrial formation of reactive oxygen species. J. Physiol. 552, 335-344 (2003).
19. Turrens, J. F. & Boveris, A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J. 191, 421-427 (1980).
20. Turrens, J. F., Alexandre, A. & Lehninger, A. L. Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria. Arch. Biochem. Biophys. 237, 408-414 (1985).
21. Cadenas, E., Boveris, A., Ragan, C. I. & Stoppani, A. O. Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria. Arch. Biochem. Biophys. 180, 248-257 (1977).
22. Boveris, A. & Chance, B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem. J. 134, 707-716 (1973).
23. Powers, S. K. & Jackson, M. J. Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol. Rev. 88, 1243-1276 (2008).
24. Davies, K. J., Quintanilha, A. T., Brooks, G. A. & Packer, L. Free radicals and tissue damage produced by exercise. Biochem. Biophys. Res. Commun. 107, 1198-1205 (1982).
25. Sjodin, B., Hellsten Westing, Y. & Apple, F. S. Biochemical mechanisms for oxygen free radical formation during exercise. Sports Med. 10, 236-254 (1990).
26. Criswell, D. et al. High intensity training-induced changes in skeletal muscle antioxidant enzyme activity. Med. Sci. Sports Exerc. 25, 1135-1140 (1993).
27. Sen, C. K. Oxidants and antioxidants in exercise. J. Appl. Physiol. 79, 675-686 (1995).
28. Venditti, P. & Di Meo, S. Antioxidants, tissue damage, and endurance in trained and untrained young male rats. Arch. Biochem. Biophys. 331, 63-68 (1996).
29. Booth, F.W. & Thomason, D. B. Molecular and cellular adaptation of muscle in response to exercise: perspectives of various models. Physiol. Rev. 71, 541-585 (1991).
30. Lin, J. et al. Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418, 797-801 (2002).
31. Handschin, C. et al. Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1alpha muscle-specific knock-out animals. J. Biol. Chem. 282, 30014-30021 (2007).
32. Arany, Z. et al. The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab. 5, 35-46 (2007).
33. Rowe, G. C. et al. Disconnecting mitochondrial content from respiratory chain capacity in PGC-1-deficient skeletal muscle. Cell Rep. 3, 1449-1456 (2013).
34. Zechner, C. et al. Total skeletal muscle PGC-1 deficiency uncouples mitochondrial derangements from fiber type determination and insulin sensitivity. Cell Metab. 12, 633-642 (2010).
35. Schuler, M., Ali, F., Metzger, E., Chambon, P. & Metzger, D. Temporally controlled targeted somatic mutagenesis in skeletal muscles of the mouse. Genesis 41, 165-170 (2005).
36. Houtkooper, R. H. & Vaz, F. M. Cardiolipin, the heart of mitochondrial metabolism. Cell Mol. Life Sci. 65, 2493-2506 (2008).
37. Zhang, J. et al. Mitochondrial phosphatase PTPMT1 is essential for cardiolipin biosynthesis. Cell Metab. 13, 690-700 (2011).
38. Mootha, V. K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267-273 (2003).
39. Patti, M. E. et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc. Natl Acad. Sci. USA 100, 8466-8471 (2003).
40. Carter, W. O., Narayanan, P. K. & Robinson, J. P. Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J. Leukoc. Biol. 55, 253-258 (1994).
41. Handschin, C. & Spiegelman, B. M. PGC-1 coactivators and the regulation of skeletal muscle fiber-type determination. Cell Metab. 13, 351 (2011); Author reply 352.
42. Lowell, B. B. & Shulman, G. I. Mitochondrial dysfunction and type 2 diabetes. Science 307, 384-387 (2005).
43. Petersen, K. F., Dufour, S., Befroy, D., Garcia, R. & Shulman, G. I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 350, 664-671 (2004).
44. Kelley, D. E., He, J., Menshikova, E. V. & Ritov, V. B. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51, 2944-2950 (2002).
45. Ling, C. et al. Multiple environmental and genetic factors influence skeletal muscle PGC-1alpha and PGC-1beta gene expression in twins. J. Clin. Invest. 114, 1518-1526 (2004).
46. Ritov, V. B. et al. Deficiency of electron transport chain in human skeletal muscle mitochondria in type 2 diabetes mellitus and obesity. Am. J. Physiol. Endocrinol. Metab. 298, E49-E58 (2010).
47. Hoeks, J. & Schrauwen, P. Muscle mitochondria and insulin resistance: a human perspective. Trends Endocrinol. Metab. 23, 444-450 (2012).
48. Szendroedi, J., Phielix, E. & Roden, M. The role of mitochondria in insulin resistance and type 2 diabetes mellitus. Nat. Rev. Endocrinol. 8, 92-103 (2012).
49. Dela, F. & Helge, J. W. Insulin resistance and mitochondrial function in skeletal muscle. Int. J. Biochem. Cell Biol. 45, 11-15 (2013).
50. Baldelli, S., Aquilano, K. & Ciriolo, M. R. PGC-1alpha buffers ROS-mediated removal of mitochondria during myogenesis. Cell Death Dis. 5, e1515 (2014).
51. Huss, J. M., Kopp, R. P. & Kelly, D. P. Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and-gamma. Identification of novel leucine-rich interaction motif within PGC-1alpha. J. Biol. Chem. 277, 40265-40274 (2002).
52. Giguere, V. Transcriptional control of energy homeostasis by the estrogenrelated receptors. Endocr. Rev. 29, 677-696 (2008).
53. Deblois, G. et al. Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity. Cancer Res. 69, 6149-6157 (2009).
54. Mootha, V. K. et al. Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc. Natl Acad. Sci. USA 101, 6570-6575 (2004).
55. Batchelor, A. H., Piper, D. E., de la Brousse, F. C.,McKnight, S. L. &Wolberger, C. The structure of GABPalpha/beta: an ETS domain-ankyrin repeat heterodimer bound to DNA. Science 279, 1037-1041 (1998).
56. Kelly, D. P. & Scarpulla, R. C. Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev. 18, 357-368 (2004).
57. Bailey, T. L. & Elkan, C. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc. Int. Conf. Intell. Syst. Mol. Biol. 2, 28-36 (1994).
58. Scarpulla, R. C. Nuclear control of respiratory gene expression in mammalian cells. J. Cell. Biochem. 97, 673-683 (2006).
59. Scarpulla, R. C. Nucleus-encoded regulators of mitochondrial function: integration of respiratory chain expression, nutrient sensing and metabolic stress. Biochim. Biophys. Acta 1819, 1088-1097 (2012).
60. Murase, T., Haramizu, S., Ota, N. & Hase, T. Suppression of the agingassociated decline in physical performance by a combination of resveratrol intake and habitual exercise in senescence-accelerated mice. Biogerontology 10, 423-434 (2009).
61. Charles, A. L. et al. Polyphenols prevent ageing-related impairment in skeletal muscle mitochondrial function through decreased reactive oxygen species production. Exp. Physiol. 98, 536-545 (2013).
62. Picard, F. et al. SRC-1 and TIF2 control energy balance between white and brown adipose tissues. Cell 111, 931-941 (2002).
63. Hamalainen, N. & Pette, D. The histochemical profiles of fast fiber types IIB, IID, and IIA in skeletal muscles of mouse, rat, and rabbit. J. Histochem. Cytochem. 41, 733-743 (1993).
64. Carson, F. L. Histotechnology: A Self Instructional Text 2nd edn (American Society for Clinical Pathology Press, 1997).
65. Duteil, D. et al. The transcriptional coregulators TIF2 and SRC-1 regulate energy homeostasis by modulating mitochondrial respiration in skeletal muscles. Cell Metab. 12, 496-508 (2010).
66. Miller, Jr F. J., Gutterman, D. D., Rios, C. D., Heistad, D. D. & Davidson, B. L. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ. Res. 82, 1298-1305 (1998).
67. Bouitbir, J. et al. Mitochondria of trained skeletal muscle are protected from deleterious effects of statins. Muscle Nerve 46, 367-373 (2012).
68. Anderson, E. J. & Neufer, P. D. Type II skeletal myofibers possess unique properties that potentiate mitochondrial H(2)O(2) generation. Am. J. Physiol. Cell Physiol. 290, C844-C851 (2006).
69. Mrakic-Sposta, S., Gussoni, M., Montorsi, M., Porcelli, S. & Vezzoli, A. Assessment of a standardized ROS production profile in humans by electron paramagnetic resonance. Oxid. Med. Cell. Longev. 2012, 973927 (2012).
70. Gupta, S., Stamatoyannopoulos, J. A., Bailey, T. L. & Noble, W. S. Quantifying similarity between motifs. Genome Biol. 8, R24 (2007).